Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an Erection

PHASE4CompletedINTERVENTIONAL
Enrollment

386

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

November 30, 2004

Conditions
Impotence
Interventions
DRUG

tadalafil

10 mg or 20 mg tadalafil tablets, as needed, no more than once a day, by mouth for 12 weeks (8 week treatment experience phase and a 4 week treatment assessment phase)

DRUG

sildenafil

25 mg, 50 mg, or 100 mg sildenafil citrate tablets, as needed, no more than once a day, by mouth for 12 weeks (8 week treatment experience phase and a 4 week treatment assessment phase)

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Plymouth

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ICOS Corporation

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT00547092 - Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an Erection | Biotech Hunter | Biotech Hunter